Speciality: Pediatrics
Description:
A warm welcome to all the medical professionals in this interesting session of evolution of vaccination. We have Dr Srivastava and Dr Jaydeep Choudhury to lead the session.
It is well known to each one of us how the science of vaccine development has evolved starting from the invention of attenuated vaccines. We are also aware about the importance of vaccination for the children or neonates.
In this webinar, a more detailed discussion is provided on the development of 6-in-1 aP combination vaccine, its usage and its importance among the pediatric population.
The 6-in-1 aP combination vaccine is referred as DTaP/Hib/HepB/IPV, stands for 'Diphtheria, Tetanus, acellular Pertussis, Hib, Hepatitis B and Inactivated Polio Vaccine'. The advantage is one single vaccine can protect the child from the mentioned diseases and save the child from taking each of vaccines separately.
Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
See More Webinars @ Hidoc Webinars
1.
Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer
2.
New CAR T-Cell Therapy Approved for Leukemia
3.
Study: One-week breast cancer radiotherapy proven as safe and effective as standard three-week treatment
4.
Too Many Kids With Sickle Cell Disease Aren't Getting Appropriate Preventive Care
5.
Guideline on management of early-stage non-small cell lung cancer released
1.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
2.
Ear Emergency: Understanding the Causes and Treatment for Auricular Hematoma
3.
Understanding Protein C Deficiency: Symptoms, Causes, and Treatment
4.
The Digital Revolution in Oncology - How Software, AI, and Data are Reshaping Cancer Care by 2025
5.
Biomimetic Nanovesicles Target Senescent-Escape Cancer Stem Cells in Breast Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
2.
Should We Use DARA Up Front As First-Line Therapy in MM?
3.
First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation